Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.41 |
| ▸ | FNTB | P49356 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.41 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7201072 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL252667 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL931570 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL252666 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL8612865 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL25211227 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL21243388 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL21291888 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL20553468 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB | |
| SCHEMBL5801833 | 1.00 | NOD1 (0.49) | NOD1MAPTSMN1; SMN2KDM4ETHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11613565-B2 | Isolated peptides derived from the B7 ligand dimer interface and uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2023-03-28 | — | — | US | claimed |
| US-20200276262-A1 | PEPTIDES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2020-09-03 | — | — | US | claimed |
| EP-3691672-A1 | PEPTIDES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) | 2020-08-12 | — | — | EP | claimed |
| US-20200148741-A1 | ISOLATED PEPTIDES DERlVED FROM THE B7 LlGAND DlMER INTERFACE AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2020-05-14 | — | — | US | claimed |
| US-10584157-B2 | Isolated peptides derived from the B7 ligand dimer interface and uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2020-03-10 | — | — | US | claimed |
| EP-3077415-B1 | REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28 | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2020-02-12 | — | — | EP | claimed |
| US-10280209-B2 | Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28 | ATOX BIO LTD. (IL) | 2019-05-07 | — | — | US | claimed |
| WO-2019069307-A1 | PEPTIDES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-04-11 | — | — | WO | claimed |
| US-9963497-B2 | Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28 | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2018-05-08 | — | — | US | claimed |
| US-20180044400-A1 | ISOLATED PEPTIDES DERlVED FROM THE B7 LlGAND DlMER INTERFACE AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2018-02-15 | — | — | US | claimed |
| EP-1613651-B1 | METHODS AND COMPOSITIONS FOR THE INHIBITION OF MODULATION OF T CELL COSTIMULATORY PATHWAY BY A PATHOGENIC AGENT | YISSUM RES DEV CO (IL) | 2015-01-07 | — | — | EP | claimed |
| US-7189398-B2 | Broad spectrum pyrogenic exotoxins antagonists and vaccines | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2007-03-13 | — | — | US | claimed |
| US-7060277-B2 | Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-06-13 | — | — | US | claimed |
| US-20020028211-A1 | BROAD SPECTRUM PYROGENIC EXOTOXINS ANTAGONISTS AND VACCINES | BAKER BOTTS LLP | 2002-03-07 | — | — | US | claimed |
| EP-0952985-A1 | BROAD SPECTRUM PYROGENIC EXOTOXINS ANTAGONISTS AND VACCINES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1999-11-03 | — | — | EP | claimed |
| US-5961970-A | OIL-IN-WATER SUBMICRON EMULSION CONTAINING A PHOSPHOLIPID AS AN EMULSIFIER, A NONIONIC SURFACTANT, AN IMMUNOGEN, AND AN AQUEOUS CONTINUOUS PHASE; FREE OF ADDED MURAMYL PEPTIDES | PHARMOS CORPORATION (US) | 1999-10-05 | — | — | US | claimed |
| WO-1998029444-A1 | BROAD SPECTRUM PYROGENIC EXOTOXINS ANTAGONISTS AND VACCINES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1998-07-09 | — | — | WO | claimed |
| US-5716637-A | LIPID CORE WHICH IS SOLID OR LIQUID CRYSTALLINE PHASE AT 25 DEGREE CENTIGRADE AND WHICH IS SURROUNDED BY ATLEAST ONE PHOSOPHOLIPID BILAYER AND ENCAPSULATING A PORTION OF AQUEOUS CONTINUOUS PHASE, IMMUNOGENS ARE ENTRAPPED BY LIPID PARTICLES | PHARMOS CORPORATION (US) | 1998-02-10 | — | — | US | claimed |
| WO-1995011700-A1 | SUBMICRON EMULSIONS AS VACCINE ADJUVANTS | PHARMOS CORP. (US) | 1995-05-04 | — | — | WO | claimed |
| WO-1994026255-A1 | SOLID FAT NANOEMULSIONS AS VACCINE DELIVERY VEHICLES | PHARMOS CORPORATION (US) | 1994-11-24 | — | — | WO | claimed |